Mitsuo Sawai
Director Ejecutivo en SAWAI GROUP HOLDINGS CO., LTD. .
Fortuna: 40 M $ al 30/04/2024
Cargos activos de Mitsuo Sawai
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SAWAI GROUP HOLDINGS CO., LTD. | Director Ejecutivo | 01/04/2021 | - |
| Presidente | 01/04/2021 | - | |
Sawai Pharmaceutical Co., Ltd.
 Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Presidente | 23/06/2020 | - |
| Director/Miembro de la Junta | 01/06/2000 | 23/06/2020 | |
| Presidente | 01/06/2008 | 23/06/2020 | |
| Ventas & Marketing | 01/06/2000 | 01/06/2008 |
Historial de carrera de Mitsuo Sawai
Estadísticas
Internacional
| Japón | 3 |
Operativa
| Chairman | 2 |
| Director/Board Member | 1 |
| President | 1 |
Sectorial
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SAWAI GROUP HOLDINGS CO., LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Sawai Pharmaceutical Co., Ltd.
Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Health Technology |
- Bolsa de valores
- Insiders
- Mitsuo Sawai
- Experiencia
